Senescence tracers

US9829481B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9829481-B2
Application numberUS-201514632475-A
CountryUS
Kind codeB2
Filing dateFeb 26, 2015
Priority dateAug 28, 2012
Publication dateNov 28, 2017
Grant dateNov 28, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The instant invention relates to novel compounds useful for visualizing cell senescence, their preparation and use. In particular, this invention relates to novel fucose and amino-quinoline derivatives useful as senescence traces and their preparation.

First claim

Opening claim text (preview).

What is claimed is: 1. Compound of formula A-L-M  (I) in which, A represents wherein, * represents the binding site to the residue represented by L, L represents *Y-(CH 2 ) n - # or wherein, Y is selected from the group consisting of O, N, S, SO and SO 2 , n is an integer from 2 to 6, * represents the binding site to the residue represented by A, and # represents the binding site to the residue represented by M, and M represents a fluorophore, a residue comprising at least one atom selected from the group consisting of 76 Br, 75 Br, 18 F, 13 C and 11 C or a combination thereof, and the salts thereof, the solvates thereof and the solvates of the salts thereof. 2. Compound according to claim 1 , wherein n is 2, 3 or 4. 3. Compound according to claim 1 , wherein M represents a fluorophore. 4. Compound according to claim 3 , wherein the fluorophore is selected from the group consisting of the xanthene derivatives, fluorescein, rhodamine, Oregon green, eosin, and Texas red, the cyanine derivatives, cyanine, indocarbocyanine, oxacarbocyanine, thiacarbocyanine, and merocyanine, the naphthalene derivatives, a dansyl or derivatives thereof, the coumarin derivatives, the oxadiazole derivatives, pyridyloxazole, nitrobenzoxadiazole and benzoxadiazole, the pyrene derivatives, the oxazine derivatives, Nile red, Nile blue and cresyl violet, the acridine derivatives, proflavin, acridine orange and acridine yellow, the arylmethine derivatives, auramine, crystal violet and malachite green, and the tetrapyrrole derivatives, porphin, phthalocyanine and bilirubin. 5. Compound according to claim 1 , wherein M is selected from 76 Br, 75 Br, 18 F, wherein, X is selected from the group consisting of Br, 76 Br, 75 Br, Cl, F and 18 F, R 1 represents hydrogen or (C 1 -C 6 )-alkyl, whereby alkyl is substituted with one to three substituents selected independently from the group consisting of hydroxy, amino, cyano, nitro, halogen, carbonyl, (C 1 -C 4 )-alkoxy, mono (C 1 -C 4 )-alkylamino and di-(C 1 -C 4 )-alkylamino, whereby R 1 represents an optionally substituted (C 1 -C 6 )-alkyl comprising at least one 76 Br, 75 Br, 18 F or 11 C if X is not 76 Br, 75 Br or 18 F, R 2 and R 3 independently from one another represent hydrogen or (C 1 -C 6 )-alkyl, whereby alkyl is substituted with one to three substituents selected independently form the group consisting of, hydroxy, amino, cyano, nitro, halogen, carbonyl, (C 1 -C 4 )-alkoxy, mono (C 1 -C 4 )-alkylamino and di-(C 1 -C 4 )-alkylamino, whereby at least one of R 2 and R 3 represents a (C 1 -C 6 )-alkyl comprising at least one 11 C or being substituted with a residue comprising at least one 76 Br, 75 Br, 18 F or 11 C, and * represents the binding site to the residue represented by L. 6. Medicament comprising a compound according to claim 1 in combination with at least one inert, non-toxic, pharmaceutically suitable excipient.

Assignees

Inventors

Classifications

  • Aging, e.g. cellular aging · CPC title

  • G01N33/582Primary

    with fluorescent label · CPC title

  • Acyclic or carbocyclic radicals, substituted by hetero rings · CPC title

  • involving human or animal cells (immunoassay G01N33/56966; immunoassays of protozoa G01N33/56905; protozoa in screening assays C12Q1/025) · CPC title

  • with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9829481B2 cover?
The instant invention relates to novel compounds useful for visualizing cell senescence, their preparation and use. In particular, this invention relates to novel fucose and amino-quinoline derivatives useful as senescence traces and their preparation.
Who is the assignee on this patent?
Univ Tuebingen Medizinische Fakultaet
What technology area does this patent fall under?
Primary CPC classification G01N33/582. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).